Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative antibiotics in breast reconstruction
NCT03742908Unknown
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Jun 2018
- Primary completion
- Oct 2021
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, open-label trial of cefazolin and clindamycin in surgical site infection (SSI) and capsular contracture, sponsored by Tianjin Medical University Cancer Institute and Hospital. Status: unknown.
02
Drugs
cefazolinclindamycin
03
Conditions
surgical site infection (SSI)capsular contracture
Beyond the preview
Go deeper on NCT03742908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03742908.